Shenzhen Ausa Pharmed Co.,Ltd Report issue

For profit Phase 4
Founded: Shenzhen China (2013)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2013
NCT01871740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shenzhen Ausa Pharmed Co.,Ltd

Active Ingredients

Drugs in Phase 4 Trials (3)

amlodipine (norvasc) (4 trials)

enalapril (vasotec) (3 trials)

folic acid (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Essential Hypertension (Phase 4)

Hyperhomocysteinemia (Phase 4)

Hypertension (Phase 4)

Kidney Diseases (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 3